St1 Biokraft acquires Danish Bio Commodities in biomethane expansion

St1 Biokraft on June 30 agreed to acquire Danish Bio Commodities, adding more than 350 GWh of production capacity and about 900 GWh of development pipeline. The transaction also gives the Nordic biomethane producer four wholly owned production assets and a 25% stake in a fifth.

Denmark already moves biomethane through the gas grid and sits inside the country’s 2050 fossil-fuel-independence target. Energinet says a transparent, flexible and secure gas market that includes biomethane plays a central role in that goal, and an International Gas Union briefing says around 80% of Danish biogas is upgraded to biomethane and that biomethane now makes up more than 40% of the gas mix.

St1 Biokraft’s acquisition supports its 2030 target of 3 TWh of own biomethane production and 6 TWh of biomethane sales and distribution, alongside a goal of 50% Nordic market share. The company also plans to invest more than €1 billion in biogas production and distribution networks across the Nordic region. It operates 12 production and upgrading facilities in Sweden and Norway, has two production plants under construction in Finland through the Suomen Lantakaasu joint venture and owns more than 70 refuelling stations and bus depots.

Miika Johansson, chief executive of St1 Biokraft: "biomethane is increasingly recognized as a scalable and investable asset class." The company’s June 2026 financing package was valued at €260 million. In the Danish assets, former owners Jysk Energi and Vestjyllands Andel completed a sales process for Danish Bio Commodities, and Plesner acted as legal adviser to Danish Bio Commodities A/S and DBC Invest A/S on the sale.

Rune Ledgaard Sørensen, chief executive of Danish Bio Commodities: "the deal creates good opportunities to develop the business further and build on its established capabilities." DBC’s platform includes six biogas plants and a development project pipeline.